5:19 PM · 5 February 2024

MorphoSys gains 37% amid rumours of possible takeover by Novartis

Novartis
Stocks
NOVN.CH, Novartis AG
-
-

Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.

The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.

MorphoSys shares are currently gaining nearly 37%.

Source: xStation

20 October 2025, 2:44 PM

IBM and Groq join forces to revolutionize AI processing

20 October 2025, 2:41 PM

US Defense Industry Preview - Has it reached its peak?

20 October 2025, 12:16 PM

Waymo: Race against the regulators

20 October 2025, 11:54 AM

Will Alibaba’s Aegaeon Revolutionize GPU Usage?

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits